Expression of Concern to: Fetal Safety of Dydrogesterone Exposure in the First Trimester of Pregnancy (Clinical Drug Investigation, (2020), 40, 7, (679), 10.1007/s40261-019-00862-w)

Gideon Koren; Daniella Gilboa; Rachel Katz

doi:10.1007/s40261-019-00884-4

Expression of Concern to: Fetal Safety of Dydrogesterone Exposure in the First Trimester of Pregnancy (Clinical Drug Investigation, (2020), 40, 7, (679), 10.1007/s40261-019-00862-w)

Gideon Koren
, Daniella Gilboa
, Rachel Katz

Department of Medicine

Research output: Contribution to journal › Comment/debate

5 Scopus citations

Abstract

The Editor-in-Chief of Clinical Drug Investigation has become aware that the original article contains a number of errors and inconsistencies.

Original language	English
Pages (from-to)	681
Number of pages	1
Journal	Clinical Drug Investigation
Volume	40
Issue number	7
DOIs	https://doi.org/10.1007/s40261-019-00884-4
State	Published - 1 Jul 2020

Access to Document

10.1007/s40261-019-00884-4

Cite this

@article{e86c648e883847a59a55eeaa8982d082,

title = "Expression of Concern to: Fetal Safety of Dydrogesterone Exposure in the First Trimester of Pregnancy (Clinical Drug Investigation, (2020), 40, 7, (679), 10.1007/s40261-019-00862-w)",

abstract = "The Editor-in-Chief of Clinical Drug Investigation has become aware that the original article contains a number of errors and inconsistencies.",

author = "Gideon Koren and Daniella Gilboa and Rachel Katz",

note = "Publisher Copyright: {\textcopyright} 2020, Springer Nature Switzerland AG.",

year = "2020",

month = jul,

day = "1",

doi = "10.1007/s40261-019-00884-4",

language = "אנגלית",

volume = "40",

pages = "681",

journal = "Clinical Drug Investigation",

issn = "1173-2563",

publisher = "Adis",

number = "7",

}

TY - JOUR

T1 - Expression of Concern to

T2 - Fetal Safety of Dydrogesterone Exposure in the First Trimester of Pregnancy (Clinical Drug Investigation, (2020), 40, 7, (679), 10.1007/s40261-019-00862-w)

AU - Koren, Gideon

AU - Gilboa, Daniella

AU - Katz, Rachel

PY - 2020/7/1

Y1 - 2020/7/1

N2 - The Editor-in-Chief of Clinical Drug Investigation has become aware that the original article contains a number of errors and inconsistencies.

AB - The Editor-in-Chief of Clinical Drug Investigation has become aware that the original article contains a number of errors and inconsistencies.

UR - https://www.scopus.com/pages/publications/85078612772

U2 - 10.1007/s40261-019-00884-4

DO - 10.1007/s40261-019-00884-4

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 31916053

AN - SCOPUS:85078612772

SN - 1173-2563

VL - 40

SP - 681

JO - Clinical Drug Investigation

JF - Clinical Drug Investigation

IS - 7

ER -

Expression of Concern to: Fetal Safety of Dydrogesterone Exposure in the First Trimester of Pregnancy (Clinical Drug Investigation, (2020), 40, 7, (679), 10.1007/s40261-019-00862-w)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this